Open-label Phase Ib Study of Preoperative Treatment With the KLK Inhibitor MDPK67b in Patients With Untreated Prostate Cancer
Latest Information Update: 09 Nov 2023
At a glance
- Drugs MDPK 67b (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Med Discovery
Most Recent Events
- 06 Nov 2023 Planned End Date changed from 31 Aug 2023 to 30 Jun 2024.
- 06 Nov 2023 Planned primary completion date changed from 31 Aug 2023 to 30 Jun 2024.
- 17 Oct 2022 New trial record